$15.08
-0.19[-1.24%]
At close: Apr 24
$15.08
0[0.00%]
After Hours: 4:00PM EDT
SI-BONE
(NASDAQ:SIBN)SI-BONE Stock (NASDAQ:SIBN), Analyst Ratings, Price Targets, Predictions
SI-BONE Inc has a consensus price target of $30.07, established from looking at the 51 latest analyst ratings. The last 3 analyst ratings were released from Needham, Piper Sandler, and Morgan Stanley on April 3, 2024, March 28, 2024, and February 27, 2024. With an average price target of $26 between Needham, Piper Sandler, and Morgan Stanley, there's an implied 72.41% upside for SI-BONE Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
Piper Sandler
Morgan Stanley
Cantor Fitzgerald
Truist Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for SI-BONE
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/03/2024 | SIBN | Buy Now | SI-BONE | $15.08 | 79.05% | Needham | David Saxon | → $27 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2024 | SIBN | Buy Now | SI-BONE | $15.08 | 65.78% | Piper Sandler | Matt O'Brien | → $25 | Initiates | → Overweight | Get Alert |
| 02/27/2024 | SIBN | Buy Now | SI-BONE | $15.08 | 72.41% | Morgan Stanley | Drew Ranieri | $25 → $26 | Maintains | Overweight | Get Alert |
| 02/27/2024 | SIBN | Buy Now | SI-BONE | $15.08 | 65.78% | Cantor Fitzgerald | Ross Osborn | $25 → $25 | Maintains | Overweight | Get Alert |
| 02/27/2024 | SIBN | Buy Now | SI-BONE | $15.08 | 59.15% | Truist Securities | Samuel Brodovsky | $26 → $24 | Reiterates | Buy → Buy | Get Alert |
| 12/22/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 72.41% | Truist Securities | David Rescott | $25 → $26 | Maintains | Buy | Get Alert |
| 12/04/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 65.78% | Needham | David Saxon | → $25 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 65.78% | Cantor Fitzgerald | Ross Osborn | $30 → $25 | Maintains | Overweight | Get Alert |
| 11/07/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 65.78% | Morgan Stanley | Drew Ranieri | $30 → $25 | Maintains | Overweight | Get Alert |
| 11/07/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 65.78% | Needham | David Saxon | $32 → $25 | Maintains | Buy | Get Alert |
| 09/26/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 98.94% | Cantor Fitzgerald | Ross Osborn | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 98.94% | Cantor Fitzgerald | Ross Osborn | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/09/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 98.94% | Cantor Fitzgerald | Ross Osborn | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/08/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 105.57% | Truist Securities | David Rescott | $33 → $31 | Maintains | Buy | Get Alert |
| 08/08/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 112.2% | Needham | David Saxon | → $32 | Reiterates | Buy → Buy | Get Alert |
| 07/19/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 118.83% | Truist Securities | David Rescott | $28 → $33 | Maintains | Buy | Get Alert |
| 07/12/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 112.2% | Needham | David Saxon | $27 → $32 | Maintains | Buy | Get Alert |
| 05/31/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 98.94% | Morgan Stanley | Drew Ranieri | $27 → $30 | Maintains | Overweight | Get Alert |
| 05/02/2023 | SIBN | Buy Now | SI-BONE | $15.08 | 98.94% | Cantor Fitzgerald | Ross Osborn | $24 → $30 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for SI-BONE (SIBN)?
The latest price target for SI-BONE (NASDAQ: SIBN) was reported by Needham on April 3, 2024. The analyst firm set a price target for $27.00 expecting SIBN to rise to within 12 months (a possible 79.05% upside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for SI-BONE (SIBN)?
The latest analyst rating for SI-BONE (NASDAQ: SIBN) was provided by Needham, and SI-BONE reiterated their buy rating.
When was the last upgrade for SI-BONE (SIBN)?
There is no last upgrade for SI-BONE.
When was the last downgrade for SI-BONE (SIBN)?
There is no last downgrade for SI-BONE.
When is the next analyst rating going to be posted or updated for SI-BONE (SIBN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SI-BONE, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SI-BONE was filed on April 3, 2024 so you should expect the next rating to be made available sometime around April 3, 2025.
Is the Analyst Rating SI-BONE (SIBN) correct?
While ratings are subjective and will change, the latest SI-BONE (SIBN) rating was a reiterated with a price target of $0.00 to $27.00. The current price SI-BONE (SIBN) is trading at is $15.08, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.